Products for Research Use Only

Recombinant Human CD44 antigen (CD44), partial , Active Protein

CAT: 0617-RPC30543-01Size: 20 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0617-RPC30543-01Size:20 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Recombinant Human CD44 antigen (CD44), partial , Active Protein is a purified Active Recombinant Protein. Purity: >90% as determined by SDS-PAGE. Host: Mammalian cell. Endotoxin Level: <1.0 EU/ug as determined by LAL method. Species: Human (Homo sapiens) . Target Name: CD44 antigen (CD44) . Accession Number: P16070; CD44. Expression Region: 21-220aa. Tag Info: C-terminal hFc-tagged. Theoretical MW: 51.0kda. Target Synonyms: CDw44; Epican; Extracellular matrix receptor III; ECMR-III; GP90 lymphocyte homing/adhesion receptor; HUTCH-I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate receptor; Phagocytic glycoprotein 1; Phagocytic glycoprotein I; PGP-I; LHR; MDU2; MDU3; MIC4 Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Short Description
Recombinant Human CD44 antigen (CD44), partial , Active Protein is a purified Active Recombinant Protein.
Accession Number
P16070; CD44
Expression Region
21-220aa
Host
Mammalian Cells
Target
CD44 antigen (CD44)
Conjugation
Unconjugated
Tag
C-Terminal hFc-Tagged
Field of Research
Cancer
Endotoxin
<1.0 EU/ug, by LAL method
Purity
>90% by SDS-PAGE
Activity
Biologically Active
Length
Partial
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
51.0kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
CDw44; Epican; Extracellular matrix receptor III; ECMR-III; GP90 lymphocyte homing/adhesion receptor; HUTCH-I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate receptor; Phagocytic glycoprotein 1; Phagocytic glycoprotein I; PGP-I; LHR; MDU2; MDU3; MIC4
Species
Human (Homo sapiens)
Protein Name
Active Recombinant Protein
AA Sequence
QIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDVSSGSSSERSSTSGGYIFYTFSTVHPIPDEDSPWITDSTDRIP